Survey the effect of glasthma in asthma

Phase 2

Recruiting

• Conditions: asthma.; Moderate persistent asthma; J45.4

• Registration Number: IRCT20210309050643N2
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Moderate asthma diagnosed by a specialist
Asthma for more than 6 months
FEV1 60-80%

Exclusion Criteria

Cognitive diseases
History of convulsive disease
Using oral or systemic corticosteroids
Pregnancy or breastfeeding
Need to be hospitalized for any reason
Smoking
Exacerbation of the disease at the beginning of the study
Hypertension or diabetes

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in patients' clinical symptoms. Timepoint: At the beginning and 4 weeks after the drug intervention. Method of measurement: International Asthma Registration Questionnaire.;Changes in respiratory test results. Timepoint: At the beginning and 4 weeks after the drug intervention. Method of measurement: Spirometry.;Changes in intestinal permeability. Timepoint: At the beginning and 4 weeks after the drug intervention. Method of measurement: lactolose/manitol ratio in urine.

Secondary Outcome Measures

Name	Time	Method
Changes in patients' quality of life. Timepoint: First and 4 weeks after drug intervention. Method of measurement: International Asthma Registration Questionnaire.